51167-770Level 3
Kalydeco (ivacaftor)
**Product type:** Human Prescription Drug
**Active ingredient:** IVACAFTOR
**Strength:** 13.4 mg/1
**Dosage form:** Granule
**Route:** Oral
**Labeler:** Vertex Pharmaceuticals Incorporated
**Marketing category:** NDA (NDA207925)
**Pharmacologic class:** Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/51167-770Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.